source
- How Kyverna rode CAR T’s autoimmune wave to the FDA’s doorPoised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.BioSpace · 11d ago↗ source
- Recon: BMS to construct AI supercomputer with Nividia; Tempus to acquire cancer diagnostic maker Personalis for $1.5BWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 11d ago↗ source
- Asia-Pacific Roundup: TGA seeks feedback on Australian regulations for digital mental health toolsAustralia’s Therapeutic Goods Administration (TGA) is holding a consultation to inform changes to the regulatory framework for digital mental health tools (DMHTs).